×
-0.0118577075098813 -0.0118577075098813 -0.0138339920948615 -0.0158498023715414 -0.00790513833992078 -0.00790513833992078 -0.0118577075098813 -0.0276679841897233
Stockreport

Celldex Therapeutics: Back Up The Truck Or Back Away? [Seeking Alpha]

CELLDEX THERAPEUTICS (CLDX)  More Company Research Source: Seeking Alpha
Last celldex therapeutics earnings: 11/7 08:01 am Check Earnings Report
PDF Celldex Therapeutics: Back Up The Truck Or Back Away?SummaryThe stock is certainly risky given the monumental late-stage clinical failure of the company’s glioblastoma immunotherapy Rintega with no other candidates in the pipeline in the final stages of development.Possible future share issuances diluting current shareholder value.Glembatumumab vedotin phase 2 results are expected by Q2 of this year. If successful, Celldex could file for regulatory approval based on Metric results. There are other combinations with glemba. [Read more]

IMPACT SNAPSHOT EVENT TIME: CLDX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS